MENU
+Compare
NEO
Stock ticker: NASDAQ
AS OF
Jul 3 closing price
Price
$7.55
Change
+$0.15 (+2.03%)
Capitalization
2.01B

NEO NeoGenomics Forecast, Technical & Fundamental Analysis

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology... Show more

NEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for NEO with price predictions
Jul 03, 2025

NEO in -0.97% downward trend, declining for three consecutive days on June 26, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where NEO declined for three days, in of 298 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

NEO broke above its upper Bollinger Band on June 10, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for NEO entered a downward trend on June 26, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 59 cases where NEO's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on June 30, 2025. You may want to consider a long position or call options on NEO as a result. In of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for NEO just turned positive on June 24, 2025. Looking at past instances where NEO's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NEO advanced for three days, in of 298 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. NEO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.086) is normal, around the industry mean (24.348). P/E Ratio (49.505) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (3.265) is also within normal values, averaging (42.660).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NEO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
NEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

NEO is expected to report earnings to rise ∞% to 2 cents per share on July 29

NeoGenomics NEO Stock Earnings Reports
Q2'25
Est.
$0.03
Q1'25
Beat
by $0.01
Q4'24
Beat
by $0.01
Q3'24
Beat
by $0.04
Q2'24
Beat
by $0.03
The last earnings report on April 29 showed earnings per share of 0 cents, beating the estimate of 0 cents. With 1.11M shares outstanding, the current market capitalization sits at 2.01B.
A.I. Advisor
published General Information

General Information

a provider of genetic and molecular testing services

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Or Nursing Services
Address
9490 NeoGenomics Way
Phone
+1 239 768-0600
Employees
2100
Web
https://www.neogenomics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PGBHX50.580.70
+1.40%
Principal Blue Chip R6
WPSZX56.710.62
+1.11%
AB Concentrated Growth Z
CFGRX53.640.57
+1.07%
Commerce Growth
RSOOX39.940.20
+0.50%
Columbia Dividend Opportunity R
OCHIX8.39-0.01
-0.12%
Oberweis China Opportunities Instl

NEO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NEO has been loosely correlated with RGEN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if NEO jumps, then RGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEO
1D Price
Change %
NEO100%
+2.03%
RGEN - NEO
43%
Loosely correlated
+0.40%
ALGN - NEO
39%
Loosely correlated
-0.08%
FLGT - NEO
39%
Loosely correlated
-0.20%
NNOX - NEO
37%
Loosely correlated
-0.19%
VCYT - NEO
36%
Loosely correlated
N/A
More